Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Multicenter Study
. 2022 Oct 1;13(1):55.
doi: 10.1186/s13293-022-00464-w.

Sex differences in clinical cognitive impairment with Lewy bodies: a Chinese multicenter study

Affiliations
Multicenter Study

Sex differences in clinical cognitive impairment with Lewy bodies: a Chinese multicenter study

Jinghuan Gan et al. Biol Sex Differ. .

Abstract

Background: Research on sex ratios of Lewy body dementia is controversial, established in small samples, and rarely focused on prodromal stage. The objective is to investigate the clinical sex ratios (men/women) and their associations with clinical features among individuals with mild cognitive impairment with Lewy bodies (MCI-LB), dementia with Lewy bodies (DLB), Parkinson's disease with mild cognitive impairment (PD-MCI), and Parkinson's disease with dementia (PDD) in China.

Methods: We conducted a multicenter cohort study, including 1038 individuals with probable MCI-LB, DLB, PD-MCI, or PDD diagnosis from 22 memory clinics in China from January 2018 to March 2022, and recorded their demographic and clinical data by reviewing medical records. Descriptive and regression analyses were used to calculate the sex ratio (men/women), and its associations with demographic and clinical data.

Results: In this study, men comprised 35.14% (men/women sex ratio = 0.54) for MCI-LB, 46.72% (men/women sex ratio = 0.88) for DLB, 63.56% (men/women sex ratio = 1.74) for PD-MCI, and 52.40% (men/women sex ratio = 1.10) for PDD. Sex ratios roughly increased with age. Men had more parkinsonism (p = 0.000) and less fluctuating cognition (p = 0.024) in MCI-LB, and those with PD-MCI had more RBD (p = 0.001). Women with PD-MCI had lower MMSE scores (β ± standard error = - 1.24 ± 0.58, p = 0.04), more irritability (0.95 ± 0.46, p = 0.04) and fluctuating cognition (- 3.41 ± 1.31, p = 0.01), and less parkinsonism (- 2.10 ± 0.97, p = 0.03) than men after adjusting for demographic and cardiometabolic conditions.

Conclusion: There were more women in DLB and MCI-LB, and more men in PD-MCI and PDD. The sex distribution, demographic, and clinical characteristics differed, which strengthened the independence and heterogeneity of the four diseases, and indicated sex-sensitive strategies for management of dementia necessary.

Keywords: Gender; Lewy body disease; Mild cognitive impairment; Parkinson’s disease; Sex ratio.

PubMed Disclaimer

Conflict of interest statement

The authors declare that they have no conflict of interest.

Figures

Fig. 1
Fig. 1
Age-specific sex ratios in patients with MCI-LB, DLB, PD-MCI and PDD. The onset age-specific (a) and age at last visit-specific (b) sex ratios are shown in this figure. And the numbers of participants in each group are described at Additional file 2. MCI-LB mild cognitive impairment with Lewy bodies, DLB dementia with Lewy bodies, PD-MCI Parkinson’s disease with mild cognitive impairment, PDD Parkinson’s disease dementia
Fig. 2
Fig. 2
Sex ratios for core clinical features of patients with MCI-LB, DLB, PD-MCI and PDD. Figures show the proportions of FLC (a), parkinsonism (b), VH (c), and RBD (d) in women and men patients in four groups. MCI-LB mild cognitive impairment with Lewy bodies; DLB dementia with Lewy bodies, PD-MCI, Parkinson’s disease with mild cognitive impairment, PDD Parkinson’s disease dementia, FLC fluctuating cognition, RBD rapid eye movement sleep behavior disorder, VH visual hallucinations. *p < 0.05, ** p < 0.01, *** p < 0.001

Similar articles

Cited by

References

    1. McKeith IG, Boeve BF, Dickson DW, Halliday G, Taylor JP, Weintraub D, et al. Diagnosis and management of dementia with Lewy bodies: fourth consensus report of the DLB Consortium. Neurology. 2017;89(1):88–100. doi: 10.1212/WNL.0000000000004058. - DOI - PMC - PubMed
    1. Taylor JP, McKeith IG, Burn DJ, Boeve BF, Weintraub D, Bamford C, et al. New evidence on the management of Lewy body dementia. Lancet Neurol. 2020;19(2):157–169. doi: 10.1016/S1474-4422(19)30153-X. - DOI - PMC - PubMed
    1. Mouton A, Blanc F, Gros A, Manera V, Fabre R, Sauleau E, et al. Sex ratio in dementia with Lewy bodies balanced between Alzheimer's disease and Parkinson's disease dementia: a cross-sectional study. Alzheimer's Res Therapy. 2018;10(1):92. doi: 10.1186/s13195-018-0417-4. - DOI - PMC - PubMed
    1. Perez F, Helmer C, Dartigues JF, Auriacombe S, Tison F. A 15-year population-based cohort study of the incidence of Parkinson's disease and dementia with Lewy bodies in an elderly French cohort. J Neurol Neurosurg Psychiatry. 2010;81(7):742–746. doi: 10.1136/jnnp.2009.189142. - DOI - PubMed
    1. Fereshtehnejad S-M, Religa D, Westman E, Aarsland D, Lökk J, Eriksdotter M. Demography, diagnostics, and medication in dementia with Lewy bodies and Parkinson's disease with dementia: data from the Swedish Dementia Quality Registry (SveDem) Neuropsychiatr Dis Treat. 2013;9:927–935. doi: 10.2147/NDT.S45840. - DOI - PMC - PubMed

Publication types